Read our latest guideline on lung cancer screening, and see our recommendations for treating high-risk patients with non-small cell lung cancer.
Guideline in Focus
June 2025
This CHEST guideline examines the literature on primary treatment of patients with stage I and II non-small cell lung cancer and consists of 17 evidence-based recommendations that surgeons can implement in their own practice.
JOIN A GUIDELINE PANEL | CHEST is recruiting members to join our guideline panels and help develop guidelines that support clinicians around the world. Submit your name for consideration by Friday, November 2. SUBMIT APPLICATION »
More thoracic oncology guidelines
LUNG CANCER
Screening for Lung Cancer | July 2021
This clinical guideline contains 16 evidence-based recommendations and an update of the evidence base for the benefits, harms, and implementation of low-dose chest CT scan screening. This 2021 guideline updates some of the prior recommendations in the 2018 version of the lung cancer screening guideline.
LUNG CANCER
Diagnosis and Management of Lung Cancer, 3rd edition | May 2013
This CHEST guideline series presents recommendations for the diagnosis, treatment, and management of patients with lung cancer, covering the full spectrum of care from initial evaluation to palliative and end-of-life care. Additional recommendations include screening, chemoprevention, and treatment of tobacco use in patients with lung cancer.
NSCLC
Evaluation and Management for High-Risk Patients With Stage I Non-small Cell Lung Cancer | December 2012
Access suggestions for evaluation and treatment of high-risk patients with non-small cell lung cancer (NSCLC), including sublobar resection with or without brachytherapy, stereotactic body radiation therapy, and radiofrequency ablation.